4//SEC Filing
Opexa Therapeutics, Inc. 4
Accession 0001293831-06-000006
CIK 0001069308operating
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 4:02 PM ET
Size
9.6 KB
Accession
0001293831-06-000006
Insider Transaction Report
Form 4
Opexa Therapeutics, Inc.pftr.ob
McWilliams David
Director
Transactions
- Award
Common Stock Option (right to buy)
2006-06-15+120,000→ 162,000 totalExercise: $5.00Exp: 2016-05-02→ Common Stock (120,000 underlying)
Holdings
- 37,500
Common Stock Option (right to buy)
Exercise: $30.00Exp: 2009-08-23→ Common Stock (37,000 underlying) - 42,000
Common Stock Option (right to buy)
Exercise: $30.00Exp: 2010-01-21→ Common Stock (5,000 underlying)
Footnotes (6)
- [F1]As adjusted to reflect a one-for-ten reverse stock split of the Issuer's common stocl effective June 15, 2006.
- [F2]40,000 shares of Issuer's common stock shall vest on May 2, 2007; 40,000 shares shall vest on May 2, 2008; and 40,000 shares shall vest on May 2, 2009; provided, however, that the reporting person remains employed with the company upon such vesting dates.
- [F3]For services rendered to the Issuer as an executive officer.
- [F4]Vests in three equal installments on January 21, 2005, January 21, 2006 and January 21, 2007.
- [F5]10,000 shares of common stock shall vest on August 23, 2004; thereafter, 10,000 shares of common stock monthly for the duration of employee's employment but only up to 36 months.
- [F6]No new options acquired.
Documents
Issuer
Opexa Therapeutics, Inc.
CIK 0001069308
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001069308
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 4:02 PM ET
- Size
- 9.6 KB